Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00872885 · ClinicalTrials.gov registry record · Phase 2
Bunionectomy Trial With GRT6005
A Phase 2 study, sponsored by Tris Pharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 258
- Enrollment target
NCT00872885: Completed Phase 2 study, sponsored by Tris Pharma.
NCT00872885 is a Phase 2 study that has completed, run by Tris Pharma. The registered enrollment target is 258 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (94% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00872885, a Phase 2 study, has completed, sponsored by Tris Pharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 258 participants
- Enrollment target
Study Summary
The purpose of the trial is to determine whether the new centrally acting analgesic is effective in comparison to placebo and an active comparator (morphine).
Interventions
- DRUG Placebo
- DRUG Morphine
- DRUG GRT6005
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 258 participants |
| Start Date | 2009-03 |
| Est. Completion | 2009-10 |
| Phase | Phase 2 |
What the finished NCT00872885 record still lists
NCT00872885 is an interventional study that assigns participants to a tested intervention. The registered 258 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (94% higher).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00872885 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00872885 about?
NCT00872885 is a clinical study titled "Bunionectomy Trial With GRT6005". The purpose of the trial is to determine whether the new centrally acting analgesic is effective in comparison to placebo and an active comparator (morphine).
What is the current status of trial NCT00872885?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 258 participants. The study started on 2009-03. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00872885?
The interventions under investigation include: Placebo (DRUG), Morphine (DRUG), GRT6005 (DRUG).
Who is sponsoring clinical trial NCT00872885?
This trial is sponsored by Tris Pharma, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00872885's enrollment target sits among peer trials
258 212th of 2000 higher than 1,787 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03785288 · 258 participants · Phase 3
Vaginal Cuff Brachytherapy Fractionation Study
- NCT04643002 · 258 participants · Phase 1
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
- NCT04924322 · 258 participants · Phase 2
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- NCT05043012 · 258 participants · NA
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia